Table 2.
Risk factors of synchronous endometrial disorders in women with EBOT
| Variables | Cases (n = 13) | Controls (n = 12) | p |
|---|---|---|---|
| Age (y) | 39.1 ± 10.4 | 50.9 ± 13.1 | 0.02a |
| Menopausal | 0.11b | ||
| No | 10 | 5 | |
| Yes | 3 | 7 | |
| AVB | 0.001b | ||
| No | 3 | 11 | |
| Yes | 10 | 1 | |
| Nulliparous | 0.03b | ||
| No | 5 | 10 | |
| Yes | 8 | 2 | |
| Tumor diameter | 5.7 ± 2.1 | 8.2 ± 4.3 | 0.07a |
| CA-125 | 0.25b | ||
| < 35 IU/L | 6 | 3 | |
| > 35 IU/L | 5 | 7 | |
| Coexisting endometriosis | 0.45b | ||
| No | 10 | 8 | |
| Yes | 3 | 4 | |
| Stage | 0.28b | ||
| I-IC1 | 11 | 8 | |
| IC2-III | 2 | 4 | |
| IEC | 0.47b | ||
| No | 12 | 10 | |
| Yes | 1 | 2 | |
| Microinvasion | 0.46b | ||
| No | 11 | 9 | |
| Yes | 2 | 3 |
aIndependent sample t test assuming equal variance
bFisher’s Exact test